Mckesson Recalls Xanax Tablets Due to Missing Primary Packaging Labels
Mckesson Packaging Services is recalling 3,492 cartons of Xanax (Alprazolam) 0.5 mg tablets because the primary blister card labels are blank and lack product information.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is not likely to cause adverse health consequences. The issue is a packaging and labeling defect (missing primary label) rather than a contamination or structural defect.
Plain-English summary
Mckesson Packaging Services is recalling 3,492 unit cartons of Xanax (Alprazolam) USP, CIV, 0.5 mg tablets. The product is identified by NDC 63739-669-10, Lot # 0111512, and an expiration date of 08/17. The recall was initiated because the primary packaging labels, specifically the blister cards, are blank and do not contain required product information such as the product name, strength, lot number, or expiry date.
The affected units were distributed to Colorado, Illinois, Louisiana, and Ohio. The tablets were manufactured by Sandoz Inc. in Princeton, NJ, and packaged by Mckesson Packaging Services.
Consumers who possess this specific lot of Xanax should stop using the product and contact their healthcare provider or pharmacist for guidance. Because the primary labels are missing, patients may be unable to verify the identity or strength of the medication, which poses a risk of medication errors.
The recalled product
- Product
- Xanax (Alprazolam) USP, CIV, 0.5 mg tablets , 10 x 10 blister cards per carton, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08805, NDC 63739-669-10
- Manufacturer
- Mckesson Packaging Services
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 0111512
- Exp. 08/17
Distribution
Related recalls
Same manufacturer · Mckesson Packaging Services
See all →- ModerateMcKesson Recalls Diltiazem CD Capsules Due to Dissolution Failures
FDA (Drugs) · 2018-05-02
- LowMcKesson Recalls Diltiazem HCl Extended-Release Capsules Due to Dissolution Failures
FDA (Drugs) · 2018-05-02
- ModerateMcKesson Recalls Diltiazem HCl Extended-Release Capsules Due to Dissolution Failures
FDA (Drugs) · 2018-05-02
- ModerateRanitidine Tablets Recalled for Failed Stability Specifications
FDA (Drugs) · 2018-03-14
- ModerateMcKesson Recalls Subpotent Megestrol Acetate Oral Suspension
FDA (Drugs) · 2018-02-14
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- HighSandoz Alprazolam Tablets Recalled for Stainless Steel Metal Particulates
FDA (Drugs) · 2014-08-13
- LowSandoz Recalls Lisinopril Tablets Due to Missing Package Insert
FDA (Drugs) · 2016-06-22
- ModerateMckesson Recalls Mislabeled Lansoprazole Capsules Due to Labeling Error
FDA (Drugs) · 2016-10-05
- ModerateAlprazolam Tablets 1mg Recalled for CGMP Deviations
FDA (Drugs) · 2022-03-09
- HighAlprazolam 0.5mg Tablets Recalled Due to Potential Cross Contamination
FDA (Drugs) · 2023-04-12
- LowMcKesson Recalls Donepezil HCl Tablets Due to Out-of-Specification Assay
FDA (Drugs) · 2017-05-03